Gut microbiota transplantations from lean donors to recipients with metabolic syndrome have shown to increase Roseburia and butyrate levels together with improved insulin sensitivity, thus suggesting the importance of butyrate-producing bacteria for blood glucose regulation in humans [29]. The gene discussed is INS; the disease is metabolic syndrome.